Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT04129710

A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/…

This is a open-label，multicenter, randomised, three-arm, phase II efficacy and safety study of ibrutinib in combination with MRE(methotrexate,rituximab,etoposid…

China120 participantsStarted 2020-01-01

Treatment: Ibrutinib, Lenalidomide